enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Management of multiple sclerosis - Wikipedia

   en.wikipedia.org/wiki/Management_of_multiple...

   Multiple sclerosis can cause a variety of symptoms including changes in sensation (hypoesthesia), muscle weakness, abnormal muscle spasms, impaired movement, difficulties with coordination and balance, problems in speech (known as dysarthria) or swallowing , visual problems (nystagmus, optic neuritis, or diplopia), fatigue and acute or chronic ...

3. Ocrelizumab - Wikipedia

   en.wikipedia.org/wiki/Ocrelizumab

   Ocrelizumab, sold under the brand name Ocrevus, is a medication used for the treatment of multiple sclerosis.It is a humanized anti-CD20 monoclonal antibody. [8] It targets CD20 marker on B lymphocytes and is an immunosuppressive drug. [10]

4. Signs and symptoms of multiple sclerosis - Wikipedia

   en.wikipedia.org/wiki/Signs_and_symptoms_of...

   Main symptoms of multiple sclerosis Symptoms and findings in multiple sclerosis. The signs and symptoms of multiple sclerosis (MS) encompass a wide range of neurological and physical manifestations, including vision problems, muscle weakness, coordination difficulties, and cognitive impairment, varying significantly in severity and progression among individuals.

5. New treatment may stop and potentially reverse some nerve ...

   www.aol.com/treatment-may-stop-potentially...

   Multiple sclerosis (MS) is a chronic disease of the nervous system that can lead to muscle weakness, vision loss, and paralysis. It occurs when the immune system attacks the myelin sheath that ...

6. Trial to assess best course of treatment for patients with MS

   www.aol.com/trial-assess-best-course-treatment...

   The trial will lead to the creation of 19 sites around the country where this treatment can be delivered, which will increase the UK capacity to offer the treatment for MS patients.

7. Ozanimod - Wikipedia

   en.wikipedia.org/wiki/Ozanimod

   Ozanimod, sold under the brand name Zeposia, is an immunomodulatory medication for the treatment of relapsing multiple sclerosis and ulcerative colitis. [3] [4] [6] [7] It acts as a sphingosine-1-phosphate receptor (S1PR) agonist, sequestering lymphocytes to peripheral lymphoid organs and away from their sites of chronic inflammation.